Tine B. Stensbøl - Concepedia

Author

Tine B. Stensbøl

Also Known As

Stensbol, T.B., Stensbol, Tine B., T B Stensbøl, T. Bryan Stensbøl, T. Stensbol, T.B. Stensbol, T.B. Stensbøl, TINE B. STENSBØL, Tine B Stensbol, Tine B Stensbøl

Publications

Citations

H-Index

Concepts

All Affiliations

Lundbeck (Denmark)University of Copenhagen Schools of Visual Arts, The Royal Danish Academy of Fine Arts Aarhus University Central Institute of Mental Health

About

Tine B. Stensbøl is an author at Lundbeck (Denmark) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	1.2K
2	Biochemistry	12	15	394
3	Social Sciences	4	4	791
4	Natural Sciences	2	2	75
5	Biomolecular Engineering	1	1	37

Tine B. Stensbøl

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
CNVs conferring risk of autism or schizophrenia affect cognition in controls Hreinn Stefánsson, Andreas Meyer‐Lindenberg, Stacy Steinberg, Nature Neuropsychological FunctioningCognitive SciencePsychiatryDevelopmental Cognitive NeuroscienceMedicine	2013	713
Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder Benny Bang‐Andersen, Thomas Ruhland, Morten Jørgensen, Journal of Medicinal Chemistry	2011	589
Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator Kenji Maeda, Haruhiko Sugino, Hitomi Akazawa, Journal of Pharmacology and Experimental Therapeutics	2014	347
Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder Arne Mørk, Alan L. Pehrson, Lise T. Brennum, Journal of Pharmacology and Experimental Therapeutics	2011	265
Novel Class of Potent 4-Arylalkyl Substituted 3-Isoxazolol GABA<sub>A</sub> Antagonists: Synthesis, Pharmacology, and Molecular Modeling Bente Frølund, Anne Techau Jørgensen, Lena Tagmose, Journal of Medicinal Chemistry	2002	134
Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator Kenji Maeda, Linda Lerdrup, Haruhiko Sugino, Journal of Pharmacology and Experimental Therapeutics	2014	126
Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1 Anders A. Jensen, Mette N. Erichsen, Christina Nielsen, Journal of Medicinal Chemistry	2009	86
Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice Michael Didriksen, Kim Fejgin, Simon Nilsson, Journal of Psychiatry and Neuroscience	2016	80
Design, Synthesis, and Pharmacological Characterization of<i>N</i>- and<i>O</i>-Substituted 5,6,7,8-Tetrahydro-4<i>H</i>-isoxazolo[4,5-<i>d</i>]azepin-3-ol Analogues: Novel 5-HT<sub>2A</sub>/5-HT<sub>2C</sub>Receptor Agonists with Pro-Cognitive Properties Anders A. Jensen, Niels Plath, Martin Holst Friborg Pedersen, Journal of Medicinal Chemistry	2013	62
Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA Tine B. Stensbøl, Lars Borre, Tommy N. Johansen, European Journal of Pharmacology Molecular PharmacologyBiochemistryMedicineMechanism Of ActionExperimental Pharmacology	1999	56

Page 1